Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
AssigneePropanc Pty Ltd
InventorsJulian Norman Kenyon, Paul Rodney Clayton, David Tosh, Fernando Felquer, Ralf Brandt
Life of this patent
Estimating the term…